http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102558058-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
| filingDate | 2012-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102558058-B |
| titleOfInvention | 1-aryl-3-substituent-5-substituted amino-4-pyrazole formamide compound and application thereof |
| abstract | The invention discloses a 1-aryl-3-substituent-5-substituted amino-4-pyrazole formamide compound and application thereof. The 1-aryl-3-substituent-5-substituted amino-4-pyrazole formamide compound has a general structural formula described in the specification, wherein R1 and R2 can be hydrogen, benzyl or alkyl independently, or can form the following groups comprising imidazolidinyl, 2-imidazolidinyl, 3-imidazolidinyl, pyrryl, 2H-pyrryl, 2-pyrrolinyl, pyrrolidyl, triazolyl, pyrazolyl, piperazinyl, pyridazinyl, pyrazinyl, triazinyl, morpholinyl and thio-morpholinyl, together with N connected with R1 and R2; R1 and R2 can be the same or different; R3 can be any one of H, CF3, Br, NO2, CH3 and OCH3; and R4 can be hydrogen, halogen, cyan, hydroxy, alkyl halide, alkoxy, alkoxy alkyl, alkyl sulphanyl or alkyl sulphanyl alkyl. The pharmacological activity result of the compound shows that the compound has an excellent restraining effect on tumor cell lines. |
| priorityDate | 2012-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.